Robert Negrin and Antony Letai
Mar 31, 2026, 16:03
Robert Negrin: Strengthening Collaboration with NCI to Advance Hematology Research
Robert Negrin, President of ASH, Professor at Stanford University, shared a post on LinkedIn:
“On behalf of the ASH leadership, thank you to Dr. Letai and NCI colleagues for meeting with us and sharing your vision and priorities for the Institute.
We also appreciated the opportunity to share details about ASH’s expanded efforts to support hematology research, promote the next generation of the hematology research workforce, and highlight other ASH programs.
We look forward to collaborating during this exciting time in science, while addressing some of the ongoing challenges we are seeing in research and clinical practice.
We look forward to seeing Dr. Letai at the annual meeting in New Orleans!”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 14:17Maha Othman: Advancing Thrombosis and Hemostasis Research at ISTH 2026
-
Jul 8, 2026, 14:07Zain Khalpey: Atrial Fibrillation as the Hidden Driver of Preventable Ischemic Stroke
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis